Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aspergillus fumigatus (14) 14
life sciences & biomedicine (13) 13
science & technology (13) 13
aspergillus fumigatus - drug effects (9) 9
humans (9) 9
microbiology (9) 9
antifungal agents - pharmacology (8) 8
fungi (7) 7
infectious diseases (7) 7
mutation (7) 7
antifungal agents (6) 6
azole-resistant (6) 6
azoles - pharmacology (6) 6
drug resistance, fungal (6) 6
aspergillosis (5) 5
aspergillus fumigatus - isolation & purification (5) 5
cytochrome p-450 enzyme system - genetics (5) 5
fungal proteins - genetics (5) 5
immunology (5) 5
antimicrobial resistance (4) 4
aspergillosis - microbiology (4) 4
aspergillus (4) 4
aspergillus fumigatus - genetics (4) 4
epidemiology (4) 4
medicine (4) 4
microbial sensitivity tests (4) 4
mycology (4) 4
pharmacology & pharmacy (4) 4
azole (3) 3
azole resistant (3) 3
drug resistance (3) 3
genotype & phenotype (3) 3
infectious and parasitic diseases (3) 3
research (3) 3
triazoles - pharmacology (3) 3
actinomycetes (2) 2
animals (2) 2
aspergillosis - drug therapy (2) 2
azole resistance (2) 2
azole-resistant a. fumigatus (2) 2
azole-resistant aspergillosis (2) 2
azoles resistant (2) 2
bacterial infections and mycoses (2) 2
care and treatment (2) 2
case report (2) 2
cyp51 (2) 2
cyp51a gene (2) 2
drug resistance, fungal - genetics (2) 2
fungal infections (2) 2
fungal proteins - antagonists & inhibitors (2) 2
fungicides (2) 2
genetic aspects (2) 2
genome, fungal (2) 2
genotyping (2) 2
health aspects (2) 2
hmg-coa reductase (2) 2
hmg1 (2) 2
inhalation (2) 2
invasive aspergillosis (2) 2
mice (2) 2
mortality (2) 2
original research (2) 2
patients (2) 2
pharmacology (2) 2
physiological aspects (2) 2
polymerase chain reaction (2) 2
polymorphism, single nucleotide (2) 2
resistance mechanisms (2) 2
skin and connective tissue diseases (2) 2
surveillance (2) 2
triazoles (2) 2
voriconazole (2) 2
voriconazole - pharmacology (2) 2
0605 microbiology (1) 1
1108 medical microbiology (1) 1
1115 pharmacology and pharmaceutical sciences (1) 1
[sdv.mp.myc]life sciences [q-bio]/microbiology and parasitology/mycology (1) 1
a. fumigatus (1) 1
abcd (1) 1
abridged index medicus (1) 1
administration, intranasal (1) 1
adolescent (1) 1
adult (1) 1
africa (1) 1
aged (1) 1
aged, 80 and over (1) 1
amino acid substitution (1) 1
antifungal (1) 1
antifungal prescription (1) 1
antifungal susceptibility (1) 1
antifungal susceptibility testing (1) 1
aspergillosis - epidemiology (1) 1
aspergillosis - invasive pulmonary aspergillosis, sinusitis, cerebral aspergillosis, disseminated disease (1) 1
aspergillosis ‐ invasive pulmonary aspergillosis, sinusitis, cerebral aspergillosis, disseminated disease (1) 1
aspergillosis, allergic bronchopulmonary - diagnosis (1) 1
aspergillosis, allergic bronchopulmonary - drug therapy (1) 1
aspergillosis, allergic bronchopulmonary - epidemiology (1) 1
aspergillus fumigatis (1) 1
aspergillus fumigatus - classification (1) 1
aspergillus fumigatus - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment
by Chowdhary, A and Sharma, C and Meis, J.F.G.M
The Journal of infectious diseases, ISSN 0022-1899, 2017, Volume 216, Issue suppl_3, pp. S436 - s444
Aspergillus fumigatis | Aspergillus | epidemiology | treatment | fumigatis | azole-esistant aspergillosis | cyp51 mutations | non cyp51 mutations | Azole-resistant aspergillosis | resistance mechanisms | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Invasive Pulmonary Aspergillosis - drug therapy | Bronchitis - epidemiology | Humans | Cytochrome P-450 Enzyme System - metabolism | Tandem Repeat Sequences | Fungal Proteins - genetics | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Invasive Pulmonary Aspergillosis - diagnosis | Bronchitis - diagnosis | Triazoles - pharmacology | Point Mutation | Bronchitis - diet therapy | Cytochrome P-450 Enzyme System - genetics | Drug Resistance, Fungal | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Fungal Proteins - metabolism | Invasive Pulmonary Aspergillosis - epidemiology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Recognition of azole-resistant aspergillosis by physicians specializing in infectious diseases, United States
by Walker, Tiffany A and Lockhart, Shawn R and Beekmann, Susan E and Polgreen, Philip M and Santibanez, Scott and Mody, Rajal K and Beer, Karlyn D and Chiller, Tom M and Jackson, Brendan R
Emerging infectious diseases, ISSN 1080-6040, 01/2018, Volume 24, Issue 1, pp. 111 - 113
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Medical colleges | Care and treatment | Physicians | Antifungal agents | Genetic aspects | Health aspects | Diseases | Index Medicus | antifungal | voriconazole | Cyp51A gene | fungi | aspergillosis | pan-azole resistance | Dispatch | azole-naive | Aspergillus fumigatus | Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States | azole
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
by Meijer, E.F.J and Dofferhoff, A.S.M and Hoiting, O and Buil, J.B and Meis, J.F
Journal of fungi (Basel), ISSN 2309-608X, 2020, Volume 6, Issue 2, p. 79
Life Sciences & Biomedicine | Microbiology | Mycology | Science & Technology | Ventilators | Bacterial infections | Mortality | Antifungal agents | Infections | Coronaviruses | Patients | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Intensive care units | Surveillance | Influenza | Aspergillosis | Mutation | Diagnosis | Drug dosages | SARS-CoV-2 | ICU | pulmonary aspergillosis | azole-resistant Aspergillus | co-infection | Aspergillus fumigatus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Successful treatment of invasive aspergillosis caused by Aspergillus parafelis in a kidney transplant recipient
by Calvo-Cano, Antonia and Garduño-Eseverri, Eugenio and Alastruey-Izquierdo, Ana and Hernández-Gallego, Román and Martínez-Gallardo, Rocío and Rodríguez-Vidigal, Francisco Félix
Medical mycology case reports, ISSN 2211-7539, 12/2020, Volume 30, pp. 35 - 38
Aspergillus | Invasive aspergillosis | Azole-resistant aspergillosis | Kidney transplant | Aspergillus parafelis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text In vitro and in vivo antifungal profile of a novel and long-acting inhaled azole, PC945, on Aspergillus fumigatus infection
by Colley, Thomas and Alanio, Alexandre and Kelly, Steven L and Sehra, Gurpreet and Kizawa, Yasuo and Warrilow, Andrew G. S and Parker, Josie E and Kelly, Diane E and Kimura, Genki and Anderson-Dring, Lauren and Nakaoki, Takahiro and Sunose, Mihiro and Onions, Stuart and Crepin, Damien and Lagasse, Franz and Crittall, Matthew and Shannon, Jonathan and Cooke, Michael and Bretagne, Stéphane and King-Underwood, John and Murray, John and Ito, Kazuhiro and Strong, Pete and Rapeport, Garth
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 05/2017, Volume 61, Issue 5, pp. e02280 - 16
Long acting | Azole | Azole resistant | Aspergillus fumigatus | CYP51 | Inhalation | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Voriconazole - pharmacology | Humans | Cells, Cultured | Fungal Proteins - antagonists & inhibitors | Itraconazole - pharmacology | Cytochrome P-450 Enzyme System | Microbial Sensitivity Tests | Triazoles - pharmacology | Animals | Aspergillus fumigatus - isolation & purification | Aspergillosis - microbiology | Benzamides - pharmacology | Mice | Aspergillosis - drug therapy | Index Medicus | Mycology | Fungal Proteins | Life Sciences | Microbiology and Parasitology | Triazoles | Voriconazole | Aspergillosis | Antifungal Agents | Benzamides | Itraconazole
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Multiple fungicide-driven alterations in azole-resistant Aspergillus fumigatus, Colombia, 2015
by Le Pape, Patrice and Lavergne, Rose-Anne and Morio, Florent and Alvarez-Moreno, Carlos
Emerging infectious diseases, ISSN 1080-6040, 01/2016, Volume 22, Issue 1, pp. 156 - 157
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Humans | Aspergillosis - microbiology | Aspergillosis - epidemiology | Azoles - pharmacology | Drug Resistance, Fungal | Population Surveillance | Aspergillus | Drug resistance in microorganisms | Usage | Fungicides | Demographic aspects | Physiological aspects | Research | Index Medicus | Letter | Colombia | fungal | Colombia, 2015 | antimicrobial resistance | fungi | aspergillosis | triazoles | Letters to the Editor | Aspergillus fumigatus | fungicide | Multiple Fungicide-Driven Alterations in Azole-Resistant
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis
by Takazono, Takahiro and Ito, Yuya and Tashiro, Masato and Nakano, Yuichiro and Hirayama, Tatsuro and Hosogaya, Naoki and Saijo, Tomomi and Yamamoto, Kazuko and Imamura, Yoshifumi and Miyazaki, Taiga and Yanagihara, Katsunori and Kohno, Shigeru and Mukae, Hiroshi and Izumikawa, Koichi
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, ISSN 1341-321X, 03/2021, Volume 27, Issue 3, pp. 537 - 539
Chronic pulmonary aspergillosis | Antifungal prescription | Aspergillus fumigatus | Patient-acquired | Azole-resistant | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Emergence of azole-resistant aspergillus fumigatus from immunocompromised hosts in India
by Dabas, Yubhisha and Xess, Immaculata and Bakshi, Sameer and Mahapatra, Manoranjan and Seth, Rachna
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 08/2018, Volume 62, Issue 8
Cyp51A mutations | Antifungal susceptibility testing | Azole-resistant Aspergillus fumigatus | Risk factor | Immunocompromised hosts | Invasive aspergillosis | India
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Non-cyp51A azole-resistant aspergillus fumigatus isolates with mutation in HMG-CoA reductase
by Hagiwara, Daisuke and Arai, Teppei and Takahashi, Hiroki and Kusuya, Yoko and Watanabe, Akira and Kamei, Katsuhiko
Emerging infectious diseases, ISSN 1080-6040, 10/2018, Volume 24, Issue 10, pp. 1889 - 1897
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Aspergillus fumigatus - drug effects | Ergosterol - metabolism | Humans | Fungal Proteins - genetics | Aspergillus fumigatus - genetics | Azoles - pharmacology | DNA, Fungal | Genotyping Techniques | Microbial Sensitivity Tests | Genome, Fungal | Aspergillus fumigatus - isolation & purification | Aspergillosis - microbiology | Cytochrome P-450 Enzyme System - genetics | Genes, Fungal | Aspergillus fumigatus - metabolism | Polymorphism, Single Nucleotide | Mutation | Drug Resistance, Fungal | Hydroxymethylglutaryl CoA Reductases - genetics | Microsatellite Repeats | Physiological aspects | Genetic aspects | Chromosomal proteins | Phytosterols | Index Medicus | azole resistance | Isolates with HMG-CoA Reductase Mutation in | Japan | non-cyp51A | Research | Non | Azole-Resistant | Gene Encoding | Hmg1 | mutation | HMG-CoA reductase | fungi | antimicrobial resistance | drug resistance | Aspergillus fumigatus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations
by Sharma, Cheshta and Nelson-Sathi, Shijulal and Singh, Ashutosh and Radhakrishna Pillai, M and Chowdhary, Anuradha
Fungal genetics and biology, ISSN 1087-1845, 11/2019, Volume 132, pp. 103265 - 103265
Non-cyp51A mechanism | Whole genome sequencing | Azole resistant Aspergillus fumigatus | mfsC | ERG6 | HMG1 | abcD | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Sequence Deletion | Genomics | Drug Resistance, Fungal - genetics | Fungal Proteins - genetics | Aspergillus fumigatus - genetics | Whole Genome Sequencing | Triazoles - pharmacology | Environmental Microbiology | Genome, Fungal | Membrane Transport Proteins - genetics | Aspergillosis - microbiology | Cytochrome P-450 Enzyme System - genetics | Polymorphism, Single Nucleotide | Mutation | Amino Acid Substitution | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text In vitro and in vivo efficacy of a novel and long-acting fungicidal azole, PC1244, on aspergillus fumigatus infection
by Colley, Thomas and Sehra, Gurpreet and Chowdhary, Anuradha and Alanio, Alexandre and Kelly, Steven L and Kizawa, Yasuo and Armstrong-James, Darius and Fisher, Matthew C and Warrilow, Andrew G. S and Parker, Josie E and Kelly, Diane E and Kimura, Genki and Nishimoto, Yuki and Sunose, Mihiro and Onions, Stuart and Crepin, Damien and Lagasse, Franz and Crittall, Matthew and Shannon, Jonathan and McConville, Matthew and King-Underwood, John and Naylor, Alan and Bretagne, Stéphane and Murray, John and Ito, Kazuhiro and Strong, Pete and Rapeport, Garth
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 05/2018, Volume 62, Issue 5
Azole | Triazole | Azole resistant | Aspergillus fumigatus | CYP51 | Inhalation | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Aspergillus fumigatus - drug effects | Trichophyton - drug effects | Epithelial Cells - metabolism | Voriconazole - pharmacology | Humans | Ergosterol - biosynthesis | Rhizopus - drug effects | Fungal Proteins - antagonists & inhibitors | Fungal Proteins - genetics | Azoles - pharmacology | Administration, Intranasal | Microbial Sensitivity Tests | Animals | Hyphae - metabolism | Aspergillus fumigatus - isolation & purification | Mannans - blood | Cytochrome P-450 Enzyme System - genetics | Mice | Candida - drug effects | Cryptococcus - drug effects | Drug Resistance, Fungal | Aspergillosis - drug therapy | Cytokines - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases
by Zhao, Yanan and Stensvold, Christen R and Perlin, David S and Arendrup, Maiken C
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2013, Volume 68, Issue 7, pp. 1497 - 1504
A. fumigatus | CYP51A PCR | Azole resistant | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aspergillus fumigatus - drug effects | Humans | Middle Aged | Child, Preschool | Infant | Male | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Young Adult | Aspergillus fumigatus - isolation & purification | Polymerase Chain Reaction | Aged, 80 and over | Adult | Female | Child | Drug Resistance, Fungal | Antifungal Agents - pharmacology | Fungal Proteins - genetics | Azoles - pharmacology | Pulmonary Aspergillosis - microbiology | Adolescent | Cytochrome P-450 Enzyme System - genetics | Denmark | Aged | Chronic Disease | Fungi | Polymerase chain reaction | Biomarkers | Mutation | Fungal infections | Drug resistance | Drug therapy | Index Medicus | Original Research | GM | azole resistant
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Management of Selected Fungal Infections after Transplantation
by Morris, Michele I
05/2011, ISBN 9780470658277, 5
management of selected fungal infections ‐ after transplantation | esophageal | C. krusei, resistant to fluconazole ‐ C. glabrata, becoming azole‐resistant | invasive (fungemia, abscess, peritonitis, hepatosplenic) | Coccidiomycosis ‐ pulmonary, meningitis, bone and joint, disseminated (Coccidioides immitis) | treatment/alternative therapy | aspergillosis ‐ invasive pulmonary aspergillosis, sinusitis, cerebral aspergillosis, disseminated disease | Cryptococcosis meningitis, brain abscess ‐ pneumonia, lung nodule, disseminated | thrush | prophylaxis | C. krusei, resistant to fluconazole - C. glabrata, becoming azole-resistant | Aspergillosis - invasive pulmonary aspergillosis, sinusitis, cerebral aspergillosis, disseminated disease | Treatment/alternative therapy | Esophageal | Prophylaxis | Invasive (fungemia, abscess, peritonitis, hepatosplenic) | Management of selected fungal infections - after transplantation | Thrush | Coccidiomycosis - pulmonary, meningitis, bone and joint, disseminated (Coccidioides immitis) | Cryptococcosis meningitis, brain abscess - pneumonia, lung nodule, disseminated
Book Chapter
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Aspergillus species and antifungals susceptibility in clinical setting in the north of Portugal: Cryptic species and emerging azoles resistance in A. fumigatus
by Pinto, Eugénia and Monteiro, Carolina and Maia, Marta and Faria, Miguel A and Lopes, Virgínia and Lameiras, Catarina and Pinheiro, Dolores
Frontiers in microbiology, ISSN 1664-302X, 07/2018, Volume 9, pp. 1656 - 1656
Azole-resistant A. fumigatus | Antifungal susceptibility | Cryptic species | Aspergillus spp | Cyp51A gene | Molecular identification | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal agents | Planning | cyp51A gene | molecular identification | cryptic species | antifungal susceptibility | azole-resistant A. fumigatus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights